Major Growth Driver Identified in 2025 Microneedle Drug Delivery Systems Market: Growing Demand For Microneedle Drug Delivery Systems Driven By Vaccine Research

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Microneedle Drug Delivery Systems Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the microneedle drug delivery systems market has seen swift expansion. It is projected to grow from a value of $5.01 billion in 2024 to approximately $5.9 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The robust growth experienced in the historical period can be linked to factors such as painless drug delivery, increased patient adherence, management of chronic diseases, and its use in cosmetic and aesthetic applications, as well as vaccine administration.

Microneedle Drug Delivery Systems Market Size Forecast: What's the Projected Valuation by 2029?
The market size of microneedle drug delivery systems is predicted to experience a swift expansion in the forthcoming years, reaching a worth of $11.44 billion in 2029 with a compound annual growth rate (CAGR) of 18.0%. This growth throughout the forecasted period is anticipated to be driven by factors such as the usage in cosmetics and aesthetics, emerging therapies, utilization in pediatric and geriatric patients, global health drives, and point-of-care testing. Key trends expected during this forecasted timeframe include the evolution of smart microneedles, advances in material science, developments in wearable technology, adoption of biodegradable materials, and continuous glucose monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/microneedle-drug-delivery-systems-global-market-report

What Are the Drivers Transforming the Microneedle Drug Delivery Systems Market?
The microneedle drug delivery systems market is expected to grow due to heightened research and the increasing demand for vaccination processes. Microneedles are seen by researchers as an alternative way to administer vaccines without causing the recipient any pain. Whilst initially developed for flu and measles, microneedle patch vaccines are also now being utilized for COVID-19 vaccine delivery. As per the information from the Office for National Statistics, a government agency in the UK, in April 2024, it was recorded that the UK government's net spending on research and development (R&D), not including the contributions to the EU R&D budget, increased in 2022 to a whopping $17.01 billion (£15.5 billion), up from $15.37 billion (£14.0 billion) in 2021. This indicates a notable increase of 10.5%. If we also factor in contributions to the EU R&D budget and related knowledge transfer activities, the total R&D net expenditure comes to $18.006 billion (£16.4 billion) in 2022, reflecting an 8.9% increase from $16.46 billion (£15.0 billion) in 2021. Consequently, the growth in the microneedle drug delivery systems market is being fueled by the surge in research and the demand for the vaccine processes.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5338&type=smp

What Long-Term Trends Will Define the Future of the Microneedle Drug Delivery Systems Market?
Leading corporations in the microneedle drug delivery sector are concentrating on product innovation, such as radiofrequency microneedle systems, to deliver trustworthy solutions to their clients. Radiofrequency microneedle systems are minimally invasive technologies that marry microneedles with radiofrequency energy to improve drug delivery and boost collagen production, used for both therapeutic and cosmetic purposes. For example, Candela, a medical aesthetic device business based in the US, debuted the Profound Matrix system in February 2023. This versatile system incorporates the Sublime, Sublative RF, and the groundbreaking Matrix Pro applicators. The Sublime and Sublative RF both make use of bipolar radiofrequency (RF) technology to improve the appearance of minor lines and wrinkles. On the other hand, the Matrix Pro applicator is focused on stimulating collagen regeneration. It boasts a series of slender microneedles that deliver short-pulse RF energy to the skin, enhancing patient comfort, reducing recovery time, and ensuring better overall outcomes.

Which Segments in the Microneedle Drug Delivery Systems Market Offer the Most Profit Potential?
The microneedle drug delivery systems market covered in this report is segmented -

1) By Technology: Hollow, Porous, Solid, Other Technologies
2) By Application: Drug Delivery, Vaccine Delivery, Other Applications
3) By End-User: Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Hollow: Solid Hollow Microneedles, Coated Hollow Microneedles
2) By Porous: Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
3) By Solid: Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
4) By Other Technologies: Dissolving Microneedles, Biodegradable Microneedles, Micro-Infusion Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5338&type=smp

Which Firms Dominate the Microneedle Drug Delivery Systems Market by Market Share and Revenue in 2025?
Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

Which Regions Offer the Highest Growth Potential in the Microneedle Drug Delivery Systems Market?
North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5338

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.